(Q54414451)

English

Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

1 reference

based on heuristic

inferred from title

author name string

T Gessner

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

H D Preisler

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

N Azarnia

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

W Bolanowska

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

W R Vogler

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

H Grunwald

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

R Joyce

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

J Goldberg

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

Medical oncology and tumor pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

23-31

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A proposed reaction mechanism for the enzymatic reductive cleavage of glycosidic bond in anthracycline antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kinetics of chloral hydrate metabolism in mice and the effect thereon of ethanol

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daunorubicin metabolism in acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative flavoprotein catalysis of anthracycline antibiotic. Reductive cleavage and oxygen consumption

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of daunomycin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3600054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3600054

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54414451&oldid=1584562348"